Mast cells in loosening of totally replaced hips

Clinical Orthopaedics and Related Research

Volumn 322, Issue , 1996, Pages 158-165

  Solovieva, Svetlana A ^a,b   Čeponis, Arnoldas ^a,b   Konttinen, Yrjö T ^a,c   Takagi, Michiaki ^a,d   Suda, Akio ^a,d   Eklund, Kari K ^a   Sorsa, Timo ^a   Santavirta, Seppo ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CELL LABELING; CELL STIMULATION; CLINICAL ARTICLE; COXITIS; FEMALE; HUMAN; MALE; MAST CELL; PRIORITY JOURNAL; PROSTHESIS LOOSENING; TOTAL HIP PROSTHESIS;

EID: 0030049138     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199601000-00020     Document Type: Article

References (54)

1. Canalis E: Regulation of Bone Remodeling. In Favus MJ (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Ed 2. New York, Raven Press 33-37, 1993.
2. Carlsson ÅS, Gentz C-F, Sanzen L: Socket loosening after hip arthroplasty. Radiographic observations in 241 cases up to 15 years. Acta Orthop Scand 57:97-100, 1986.
3. Chiba J, Rubash HE, Kim KJ, Iwaki Y: The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop 300:304-312, 1994.
4. Claman HN: On scleroderma. Mast cells, endothelial cells, and fibroblasts. JAMA 262: 1206-1209, 1989.
5. Crisp AJ, Chapman CM, Kirkham SE, et al: Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 27:845-851, 1984.
6. Engh CA, Hooten Jr JP, Zettl-Schaffer KF, et al: Porous-coated total hip replacement. Clin Orthop 298:89-96, 1994.
7. Galli SJ, Tsai M, Wershil BK: The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 142:965-974, 1993.
8. Godfrey HP, Ilardi C, Engber W, Graziano FM: Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 27: 852-856, 1984.
9. Goodman S, Aspenberg P: Effect of amplitude of micromotion on bone ingrowth into titanium chambers implanted in the rabbit tibia. Biomaterials 13:944-948, 1992.
10. Goodman S, Wang J-S, Regula D, Aspenberg P: T-lymphocytes are not necessary for particulate polyethylene-induced macrophage recruitment. Histologic studies of the rat tibia. Acta Orthop Scand 65:157-160, 1994.
11. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TFN-alpha/cachectin. Nature 346: 274-276, 1990.
12. Gruber BL, Marchese MJ, Carsons SE, Schlechter NM: Human mast cell chymase degrades basement membrane components laminin, fibronectin, and type IV collagen. Clin Res 38:578A, 1990.
13. Hunt LW, Colby TV, Weiler DA, et al: Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: Quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin Proc 67:941-948, 1992.
14. Irani A-MA, Craig SS, DeBlois G, et al: Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 138: 4381-4386, 1987.
15. TC, cells. J Immunol 147:247-253, 1991.
16. T cells in the skin and evidence of mast cell activation. Arthritis Rheum 35:933-939, 1992.
17. Irani AA, Schlechter NM, Craig SS, et al: Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 83: 4464-4468, 1986.
18. Jakobsson A, Sorbo J, Norrby K: Protamine and mast-cell-mediated angiogenesis in the rat. J Exp Pathol 71:209-217, 1990.
19. Jordana M: Mast cells and fibrosis-who's on first? Am J Respir Cell Mol Biol 8:7-8, 1993.
20. Kielty CM, Lees M, Shuttleworth CA, Woolley D: Catabolism of intact type VI collagen microfibrils: Susceptibility to degradation by serine proteinases. Biochem Biophys Res Commun 191:1230-1236, 1993.
21. Kim KJ, Rubash HE, Wilson SC, et al: A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop 287:142-152, 1993.
22. Kitamura Y, Yokoyama M, Matsuda H, et al: Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes. Nature 291:159-160, 1981.
23. Krejci NC, Knapp DM, Rudd RJ, et al: Dermal mast cell granules bind interstitial procollagenase and collagenase. J Invest Dermatol 98:748-752, 1992.
24. Maguire Jr JK, Coscia MF, Lynch MH: Foreign body reaction to polymeric debris following total hip arthroplasty. Clin Orthop 216:213-223, 1987.
25. Manley MT, Serekian P: Wear debris. An environmental issue in total joint replacement. Clin Orthop 298:137-146, 1994.
26. Marks RM, Roche WR, Czerniecki M, et al: Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 55:289-294, 1986.
27. Metcalfe DD: Effector cell heterogeneity in immediate hypersensitivity reactions. Clin Rev Allergy 1:311-325,1983.
28. Mican JM, Metcalfe DD: Arthritis and mast cell activation. J Allergy Clin Immunol 86:677-683, 1990.
29. Ohlin A, Kindblom L-G: The ultrastructure of the tissue surrounding the Christiansen total hip. Acta Orthop Scand 59:629-634, 1988.
30. Pazzaglia UE, Pringle JAS: The role of macrophages and giant cells in loosening of joint replacement. Arch Orthop Trauma Surg 107:20-26, 1988.
31. Peters SP, Schleimer RP, Naclerio RM, et al: The pathophysiology of human mast cells. In vitro and in vivo function. Am Rev Respir Dis 135:1196-1200, 1987.
32. Remagen W, Morscher E: Histological results with cement-free implanted hip joint sockets of polyethylene. Arch Orthop Trauma Surg 103:145-151, 1984.
33. Rorabeck CH, Bourne RB, Laupacis A, et al: A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty. Cost-effectiveness and its impact on health-related quality of life. Clin Orthop 298:156-164, 1994.
34. Ruoss SJ, Hartmann T, Caughey GH: Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88:493-499, 1991.
35. Santavirta S, Gristina A, Konttinen YT: Cemented versus cementless hip arthroplasty. A review of prosthetic biocompatibility. Acta Orthop Scand 63:225-232, 1992.
36. Santavirta S, Konttinen YT, Bergroth V, et al: Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg 72A:252-258, 1990.
37. Santavirta S, Konttinen YT, Hoikka V, Eskola A: Immunopathological response to loose cementless acetabular components. J Bone Joint Surg 73B: 38-42, 1991.
38. Santavirta S, Pajamaki J, Eskola A, et al: Proliferative cell response to loosening of total hip replacements: A cytofluorographic cell cycle analysis. Arch Orthop Trauma Surg 111:43-46, 1991.
39. Santavirta S, Sorsa T, Konttinen YT, et al: Role of mesenchymal collagenase in the loosening of total hip prosthesis. Clin Orthop 290:206-215, 1993.
40. TC type of human mast cell. J Immunol 145: 2652-2661, 1990.
41. Schwartz LB, Bradford TR, Irani A-MA, et al: The major enzymes of human mast cell secretory granules. Am Rev Respir Dis 135:1186-1189, 1987.
42. Seibold JR, Giorno RC, Claman HN: Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 33:1702-1709, 1990.
43. Stack MS, Johnson DA: Human mast cell tryptase activates single-chain urinary-type plasminogen activator (prourokinase). J Biol Chem 269:9416-9419, 1994.
44. Stevens RL, Austen KF: Recent advances in the cellular and molecular biology of mast cells. (A Review). Immunol Today 10:381-386, 1989.
45. Sueki H, Whitaker D, Buchsbaum M, Murphy GF: Novel interactions between dermal dendrocytes and mast cells in human skin. Lab Invest 69:160-172, 1993.
46. Takagi M, Konttinen YT, Lindy O, et al: Gelatinase/type IV collagenases in the loosening of total hip replacement endoprosthesis. Clin Orthop 306: 136-144, 1994.
47. Takagi M, Konttinen YT, Santavirta S, et al: Matrix metalloproteinases and serine proteinases in loosening of endoprostheses. In Machtey I (ed). Progress in Rheumatology. Petach Tikva, Golda Medica Center 5:26-31, 1993.
48. Takagi M, Konttinen YT, Santavirta S, et al: Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand 65:281-286, 1994.
49. 1-antitrypsin in the local host reaction to loosening of total hip prosthesis. J Bone Joint Surg 77A:16-25, 1995.
50. 1-antitrypsin, in the periprosthetic connective tissue matrix around loose total hip prostheses. J Orthop Res 13:296-304, 1995.
51. Takagi M, Santavirta S, Konttinen YT, et al: Proteolytic potential of matrix metalloproteinases and serine proteinases in the host response to THR endoprosthesis. Bioceramics 7:311-316, 1994.
52. Thompson HL, Burbelo PD, Yamada Y, et al: Mast cells chemotax to laminin with enhancement after IgE-mediated activation. J Immunol 143: 4188-4192, 1989.
53. εRI-mediated signals. Clin Exp Allergy 23: 270-275, 1993.
54. Walsh LJ, Trinchieri G, Waldorf HA, et al: Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 88: 4220-4224, 1991.